Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Simply put, there’s no turning back from the digital transformation that’s underway and continuing to pick up steam. This is why it’s critical for the people who design and use healthcare technology to always consider the influence it can have.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Livongo and Dexcom struck a partnership on Monday that would combine Dexcom’s continuous glucose monitors with Livongo’s software. At the StartUp Health Conference, Livongo President Jennifer Schneider said its work with Dexcom would create a new stream of data for both companies.
An alternative way of testing glucose levels without finger pricking is a great solution for young kids and teens.
More than 29 million Americans have diabetes and 86 million have prediabetes. Purdue University researchers are focusing on new innovations in treatment.
A research team at the University of Virginia School of Medicine is looking to automate the monitoring of blood glucose levels and insulin for type 1 diabetes patients.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.